Molecular mechanisms of membrane impermeability in clinical isolates of Enterobacteriaceae exposed to imipenem selective pressure
- PMID: 27256585
- DOI: 10.1016/j.ijantimicag.2016.04.016
Molecular mechanisms of membrane impermeability in clinical isolates of Enterobacteriaceae exposed to imipenem selective pressure
Abstract
Intrinsic mechanisms leading to carbapenem-induced membrane impermeability and multidrug resistance are poorly understood in clinical isolates of Enterobacteriaceae. In this study, molecular behaviours during the establishment of membrane impermeability in members of the Enterobacteriaceae family under imipenem selective pressure were investigated. Clinical isolates (n = 22) exhibiting susceptibility to multiple antibiotics or characterised as extended-spectrum β-lactamase (ESBL)- or AmpC-producers were submitted to progressive passages on Mueller-Hinton agar plates containing subclinical concentrations of imipenem [0.5 × the minimum inhibitory concentration (MIC)]. Changes in outer membrane permeability were evaluated by determination of antimicrobial MICs, sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), and gene expression analysis related to membrane permeability (i.e. omp35-like, omp36-like and acrA) and regulatory mechanisms (i.e. marA and ompR) by quantitative reverse transcription PCR. Following imipenem induction, 73% of isolates showed increased carbapenem MICs by ≥2 doubling dilutions. At an early stage of treatment, imipenem modulated the expression of porins and efflux pump genes, represented by a reduction of 78% in omp36-like and a two-fold increase in acrA expression. Transcriptional factors marA and ompR were also affected by imipenem induction, increasing mRNA expression by 14- and 4-fold, respectively. High marA expression levels were associated with higher values of acrA expression. These results suggest that imipenem is an important factor in the development of an adaptive response to carbapenems by regulating key genes involved in the control of efflux pumps and porins, which could lead to a multidrug-resistant profile in clinical isolates, contributing to possible treatment failure.
Keywords: Carbapenem resistance; Enterobacteriaceae; Imipenem selective pressure; Membrane impermeability.
Copyright © 2016 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
Similar articles
-
The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.Microb Drug Resist. 2015 Dec;21(6):577-80. doi: 10.1089/mdr.2014.0226. Epub 2015 May 6. Microb Drug Resist. 2015. PMID: 25945596
-
An adaptive response of Enterobacter aerogenes to imipenem: regulation of porin balance in clinical isolates.Int J Antimicrob Agents. 2013 Feb;41(2):130-6. doi: 10.1016/j.ijantimicag.2012.10.010. Epub 2012 Dec 29. Int J Antimicrob Agents. 2013. PMID: 23280442
-
lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa.Microbiologyopen. 2019 Nov;8(11):e844. doi: 10.1002/mbo3.844. Epub 2019 Apr 12. Microbiologyopen. 2019. PMID: 30977288 Free PMC article.
-
Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens.Curr Drug Targets. 2008 Sep;9(9):750-9. doi: 10.2174/138945008785747824. Curr Drug Targets. 2008. PMID: 18781921 Review.
-
Stress responses, outer membrane permeability control and antimicrobial resistance in Enterobacteriaceae.Microbiology (Reading). 2018 Mar;164(3):260-267. doi: 10.1099/mic.0.000613. Epub 2018 Jan 25. Microbiology (Reading). 2018. PMID: 29458656 Review.
Cited by
-
Risk factors and prediction model for carbapenem-resistant organism infection in sepsis patients.Eur J Med Res. 2025 Mar 25;30(1):201. doi: 10.1186/s40001-025-02448-z. Eur J Med Res. 2025. PMID: 40128899 Free PMC article.
-
Carbapenem-resistant Enterobacteriaceae in the livestock, humans and environmental samples around the globe: a systematic review and meta-analysis.Sci Rep. 2024 Jul 15;14(1):16333. doi: 10.1038/s41598-024-64992-8. Sci Rep. 2024. PMID: 39009596 Free PMC article.
-
Emerging Transcriptional and Genomic Mechanisms Mediating Carbapenem and Polymyxin Resistance in Enterobacteriaceae: a Systematic Review of Current Reports.mSystems. 2020 Dec 15;5(6):e00783-20. doi: 10.1128/mSystems.00783-20. mSystems. 2020. PMID: 33323413 Free PMC article. Review.
-
Cefepime versus carbapenems for treatment of AmpC beta-lactamase-producing Enterobacterales bloodstream infections.Eur J Clin Microbiol Infect Dis. 2024 Feb;43(2):213-221. doi: 10.1007/s10096-023-04715-5. Epub 2023 Nov 23. Eur J Clin Microbiol Infect Dis. 2024. PMID: 37993680 Free PMC article.
-
A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria.J Antimicrob Chemother. 2023 Apr 3;78(4):1000-1008. doi: 10.1093/jac/dkad035. J Antimicrob Chemother. 2023. PMID: 36790896 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical